Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cachia

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Neuro-Oncology Practice|August 7, 2019
Case-based review: ependymomas in adultsDavid Cachia, Derek R Johnson, Timothy J Kaufmann, et al.
Neurosurgery|September 10, 2015
Spinal Anaplastic Oligodendroglioma With Oligodendrogliomatosis: Molecular Markers and Management: Case ReportBen A Strickland, David Cachia, Ali Jalali, et al.
Brain Tumor Pathology|November 13, 2014
C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcomaDavid Cachia, Khalida Wani, Marta Penas-Prado, et al.
Neuro-Oncology|October 11, 2017
Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastomaJacob J Mandel, Shlomit Yust-Katz, Akash J Patel, et al.
Journal of the Neurological Sciences|September 1, 2020
Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessmentArabinda Das, Mohammed Alshareef, Guilherme Bastos Ferreira Porto, et al.
Pituitary|April 24, 2016
Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinomaCarlos Kamiya-Matsuoka, David Cachia, Steven G Waguespack, et al.
Journal of Neuro-Oncology|September 11, 2015
Primary and secondary gliosarcomas: clinical, molecular and survival characteristicsDavid Cachia, Carlos Kamiya-Matsuoka, Jacob J Mandel, et al.
Cancer Investigation|May 23, 2020
<i>In Vitro</i> Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma CellsArabinda Das, Jaime L Martinez Santos, Mohammed Alshareef, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2018
Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastomaArabinda Das, Fraser Henderson, Stephen Lowe, et al.
Journal of Neuro-Oncology|February 19, 2024
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannomaPhioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Neuro-Oncology Practice|August 7, 2019
Case-based review: ependymomas in adultsDavid Cachia, Derek R Johnson, Timothy J Kaufmann, et al.
Neurosurgery|September 10, 2015
Spinal Anaplastic Oligodendroglioma With Oligodendrogliomatosis: Molecular Markers and Management: Case ReportBen A Strickland, David Cachia, Ali Jalali, et al.
Brain Tumor Pathology|November 13, 2014
C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcomaDavid Cachia, Khalida Wani, Marta Penas-Prado, et al.
Neuro-Oncology|October 11, 2017
Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastomaJacob J Mandel, Shlomit Yust-Katz, Akash J Patel, et al.
Journal of the Neurological Sciences|September 1, 2020
Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessmentArabinda Das, Mohammed Alshareef, Guilherme Bastos Ferreira Porto, et al.
Pituitary|April 24, 2016
Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinomaCarlos Kamiya-Matsuoka, David Cachia, Steven G Waguespack, et al.
Journal of Neuro-Oncology|September 11, 2015
Primary and secondary gliosarcomas: clinical, molecular and survival characteristicsDavid Cachia, Carlos Kamiya-Matsuoka, Jacob J Mandel, et al.
Cancer Investigation|May 23, 2020
<i>In Vitro</i> Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma CellsArabinda Das, Jaime L Martinez Santos, Mohammed Alshareef, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2018
Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastomaArabinda Das, Fraser Henderson, Stephen Lowe, et al.
Journal of Neuro-Oncology|February 19, 2024
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannomaPhioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, et al.
Pageof 6